Latest Ratios: P/E Ratio 38.9x · EV/EBITDA 8.3x · ROE 4.5%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $967M | $1.8B | $2.7B | $1.9B | $13.4B | $11.1B | — | — |
| Enterprise Value | $1.4B | $1.2B | $1.9B | $2.8B | $1.9B | $13.2B | $10.8B | — | — |
| P/E Ratio → | 38.92 | 31.77 | 111.24 | — | — | — | — | — | — |
| P/S Ratio | 1.44 | 1.21 | 2.30 | 3.66 | 2.51 | 17.97 | 20.12 | — | — |
| P/B Ratio | 1.92 | 1.57 | 2.52 | 3.61 | 2.36 | 16.11 | 15.58 | — | — |
| P/FCF | 7.00 | 5.89 | 16.06 | 33.31 | 21.01 | 92.84 | 116.01 | — | — |
| P/OCF | 6.85 | 5.76 | 9.92 | 19.88 | 13.11 | 74.94 | 84.37 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.57 | 2.42 | 3.72 | 2.46 | 17.65 | 19.64 | — | — |
| EV / EBITDA | 8.29 | 7.23 | 14.17 | 34.56 | 33.69 | 274.47 | — | — | — |
| EV / EBIT | 16.36 | 12.59 | 22.74 | 2411.66 | 171.07 | 977.30 | — | — | — |
| EV / FCF | — | 7.59 | 16.90 | 33.78 | 20.57 | 91.18 | 113.25 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.8% | 92.8% | 93.9% | 91.1% | 91.5% | 93.7% | 94.6% | 96.4% | 97.6% |
| Operating Margin | 11.0% | 11.0% | 8.3% | -3.6% | 0.2% | 1.8% | -50.1% | 36.0% | 31.0% |
| Net Profit Margin | 3.8% | 3.8% | 2.1% | -1.2% | -4.3% | -3.4% | -53.3% | 17.0% | 17.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.5% | 4.5% | 2.2% | -1.1% | -4.0% | -3.3% | -41.3% | — | — |
| ROA | 2.2% | 2.2% | 1.1% | -0.6% | -2.0% | -1.6% | -31.6% | 18.8% | 13.9% |
| ROIC | 7.6% | 7.6% | 6.1% | -2.6% | 0.2% | 1.9% | -920.1% | — | — |
| ROCE | 7.2% | 7.2% | 4.8% | -1.8% | 0.1% | 0.9% | -31.3% | 42.9% | 25.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.88 | 0.88 | 0.75 | 0.93 | 0.88 | 0.84 | 0.99 | — | — |
| Debt / EBITDA | 3.14 | 3.14 | 4.01 | 8.82 | 12.82 | 14.65 | — | 4.64 | 8.30 |
| Net Debt / Equity | — | 0.46 | 0.13 | 0.05 | -0.05 | -0.29 | -0.37 | — | — |
| Net Debt / EBITDA | 1.63 | 1.63 | 0.70 | 0.48 | -0.72 | -4.98 | — | 4.47 | 7.90 |
| Debt / FCF | — | 1.71 | 0.84 | 0.47 | -0.44 | -1.65 | -2.76 | 8.83 | 16.45 |
| Interest Coverage | 2.33 | 2.33 | 1.59 | 0.02 | 0.32 | 0.57 | -9.87 | 2.67 | 3.36 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | 2.61 | 5.32 | 7.12 | 12.05 | 13.42 | 18.24 | 2.59 | 4.40 |
| Quick Ratio | 2.61 | 2.61 | 5.32 | 7.12 | 12.05 | 13.42 | 18.24 | 2.59 | 4.40 |
| Cash Ratio | 1.06 | 1.06 | 3.62 | 5.49 | 9.92 | 11.60 | 16.27 | 0.78 | 2.08 |
| Asset Turnover | — | 0.57 | 0.57 | 0.47 | 0.48 | 0.46 | 0.37 | 1.00 | 0.79 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 116.74 | 74.09 | 77.86 | 57.93 | 61.90 | 64.49 | 52.20 | 51.23 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | 3074.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.6% | 3.1% | 0.9% | — | — | — | — | — | — |
| FCF Yield | 14.3% | 17.0% | 6.2% | 3.0% | 4.8% | 1.1% | 0.9% | — | — |
| Buyback Yield | 18.0% | 21.4% | 8.7% | 3.8% | 5.3% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 18.0% | 21.4% | 8.7% | 3.8% | 5.3% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $357M | $392M | $410M | $413M | $410M | $275M | $363M | $363M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GDRX stock.
GoodRx Holdings, Inc.'s current P/E ratio is 38.9x. The historical average is 71.5x. This places it at the 50th percentile of its historical range.
GoodRx Holdings, Inc.'s current EV/EBITDA is 8.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 22.4x.
GoodRx Holdings, Inc.'s return on equity (ROE) is 4.5%. The historical average is -7.2%.
Based on historical data, GoodRx Holdings, Inc. is trading at a P/E of 38.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
GoodRx Holdings, Inc. has 92.8% gross margin and 11.0% operating margin. Operating margin between 10-20% is typical for established companies.
GoodRx Holdings, Inc.'s Debt/EBITDA ratio is 3.1x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
PBM disintermediation and flat growth
Metrics are mathematically derived from official filings.
Gross Margin Volatility Masks Core Stability
Gross margin swung from 93.4% in 2025Q1 to 78.4% in 2026Q1 before recovering to 89.5% in 2026Q2, per quarterly filings, indicating instability in cost of revenue despite a structurally high-margin model.
The 15-point gross margin swing in 2026Q1 likely reflects one-time adjustments or contract renegotiations, but the recovery to 89.5% suggests the underlying take-rate remains intact. Operating margin has hovered between 7.5% and 13.6% over the past year, with net margin consistently below 6.3%, implying that heavy SG&A spending—particularly sales and marketing—absorbs most of the gross profit. This gap between gross and net margins underscores that GDRX's earning power is constrained by customer acquisition costs, not by the cost of delivering its digital service.
ROIC Stagnates Near 2% Despite Asset-Light Model
ROIC has remained below 2.3% for the past ten quarters, per financial statements, despite an asset-light model with minimal capex, indicating that returns on invested capital are not compounding and may reflect a mature, low-growth phase.
ROIC peaked at 2.3% in 2025Q2 and has since drifted to 1.9% in 2026Q2, while ROE has stayed under 2% throughout. The low returns are driven by a combination of thin net margins and a large invested capital base, which includes significant goodwill and intangibles from prior acquisitions. Even with high gross margins, the company's inability to convert revenue into meaningful net income limits return generation, suggesting that capital allocation—such as the $300M+ in buybacks—has not yet improved per-share returns.
DSO Spike Signals Collection Strain
Days sales outstanding jumped from 74 days in 2024Q4 to 341 days in 2026Q2, per quarterly data, a dramatic deterioration that may indicate slower collections from PBM partners or a change in revenue mix, warranting close monitoring.
The DSO increase is anomalous and could be driven by timing of manufacturer solutions revenue or a shift in payment terms with major PBMs. Meanwhile, DPO has been volatile, ranging from 36 to 255 days, and the cash conversion cycle is not calculable due to missing DIO data, but the working capital swings have been significant, as seen in cash flow statements. This inefficiency in receivables may pressure liquidity, especially as the current ratio has fallen from 5.32 to 1.38 over the same period, suggesting that the company is holding less buffer against collection delays.
Debt Coverage Thins as Interest Costs Rise
Interest coverage has declined from 2.82 in 2025Q2 to 2.58 in 2026Q2, per reported figures, while D/EBITDA has risen to 21.32, indicating that debt service is becoming less comfortable relative to earnings.
Although the D/E ratio remains low at 0.83, the D/EBITDA multiple of 21.32 is elevated because EBITDA is depressed by high SG&A and non-cash charges. The company's debt level has stayed near $540M, but with flat revenue and volatile margins, the cushion for interest payments is thinning. Investors should monitor whether the recent EPS miss and lack of guidance signal further pressure on EBITDA, which would make the current leverage less sustainable.
Liquidity Buffer Thins Rapidly
The current ratio has fallen from 5.32 in 2024Q4 to 1.38 in 2026Q2, per balance sheet data, while cash dropped from $448M to $296M, indicating a shrinking liquidity cushion that may limit flexibility.
The quick ratio equals the current ratio, suggesting no inventory dependence, which is typical for a digital platform. However, the rapid decline in liquidity is concerning given the DSO spike and volatile cash flow. While the company still has positive working capital, the trend suggests that if collections continue to slow or if operating losses recur, the buffer could erode further. The asset-light model provides some resilience, but the shrinking cash position reduces the ability to weather a prolonged downturn or fund strategic initiatives.
Misapplied EV/EBITDA in a High-SBC Model
EV/EBITDA of 9.09 understates true valuation because EBITDA excludes stock-based compensation, which averaged $20M per quarter and often exceeded net income, per SEC filings, making the multiple appear artificially low.
For GDRX, SBC is a real economic cost that dilutes shareholders, yet it is excluded from EBITDA. Adjusting for SBC would reduce EBITDA significantly, potentially doubling the EV/EBITDA multiple. A more appropriate metric is EV/EBIT or EV/FCF, where FCF is adjusted for SBC, to capture the true cash-generative capacity. The forward EV/EBITDA of 4.95 is even more misleading, as it likely assumes a recovery in EBITDA that may not materialize given flat revenue growth and persistent marketing spend.